Cargando…

PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design

INTRODUCTION: Overtreatment of localised prostate cancer is substantial despite increased use of active surveillance. No randomised trials help define how to monitor patients or when to initiate treatment with curative intent. METHODS AND ANALYSIS: A randomised, multicentre, intervention trial desig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahlberg, Mats Steinholtz, Adami, Hans-Olov, Beckmann, Kerri, Bertilsson, Helena, Bratt, Ola, Cahill, Declan, Egevad, Lars, Garmo, Hans, Holmberg, Lars, Johansson, Eva, Rannikko, Antti, Van Hemelrijck, Mieke, Jäderling, Fredrik, Wassberg, Cecilia, Åberg, Ulrika W N, Bill-Axelson, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707666/ https://www.ncbi.nlm.nih.gov/pubmed/31444180 http://dx.doi.org/10.1136/bmjopen-2018-027860

Ejemplares similares

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022)

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
por: Van Hemelrijck, Mieke, et al.
Publicado: (2010)

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
por: Ahlberg, Mats S., et al.
Publicado: (2023)

Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study
por: Bergengren, Oskar, et al.
Publicado: (2019)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Changes in lifestyle among prostate cancer survivors: A nationwide population‐based study
por: Bergengren, Oskar, et al.
Publicado: (2020)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
por: Wulaningsih, Wahyu, et al.
Publicado: (2012)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
por: Van Hemelrijck, Mieke, et al.
Publicado: (2022)

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Mortality following Hip Fracture in Men with Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
por: Bosco, Cecilia, et al.
Publicado: (2018)

Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
por: Robinson, David, et al.
Publicado: (2013)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

How to model temporal changes in comorbidity for cancer patients using prospective cohort data
por: Lindhagen, Lars, et al.
Publicado: (2015)

How to measure temporal changes in care pathways for chronic diseases using health care registry data
por: Ventimiglia, Eugenio, et al.
Publicado: (2019)

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
por: Melvin, Jennifer C, et al.
Publicado: (2017)

Iron metabolism and risk of cancer in the Swedish AMORIS study
por: Gaur, Anjali, et al.
Publicado: (2013)

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
por: Crawley, Danielle, et al.
Publicado: (2018)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
por: George, Gincy, et al.
Publicado: (2023)

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
por: Russell, Beth, et al.
Publicado: (2018)

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Serum lactate dehydrogenase and survival following cancer diagnosis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
por: Crawley, Danielle, et al.
Publicado: (2018)

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
por: Santaolalla, Aida, et al.
Publicado: (2019)

Serum inflammatory markers and colorectal cancer risk and survival
por: Ghuman, Sundeep, et al.
Publicado: (2017)

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
por: Yiu, Andrew, et al.
Publicado: (2017)

Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study
por: Thomsen, Frederik B., et al.
Publicado: (2021)

Serum Glucose and Fructosamine in Relation to Risk of Cancer
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
por: Ghoshal, Arunangshu, et al.
Publicado: (2017)

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
por: Lycken, Magdalena, et al.
Publicado: (2022)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
por: Melvin, Jennifer C, et al.
Publicado: (2016)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nc7ma1alpc1marlfie8b4gmrk3